Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology | Hematology
Clinical Trials: Hematologic Neoplasms
A listing of clinical trials currently looking for volunteers to enroll in Hematologic Neoplasms studies. Click on the closest city to find more detailed information on a research study in your area.
Arizona
Scottsdale : Mayo Clinic Arizona - Cancer Clinical Research Unit Updated
A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers
Scottsdale : Site Reference ID/Investigator# 59324 Updated
ABT-348 as Monotherapy and in Combination With Azacitidine to Treat Advanced Hematologic Malignancies
Scottsdale : Investigational Site Number 840003
Dose Escalation Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies
Arkansas
Fayetteville : Research Site Updated
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Little Rock : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
California
Anaheim : Research Site Updated
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Bakersfield : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Berkeley : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Burbank : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Campbell : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
View More »
La Jolla : Pfizer Investigational Site
A Study Of PF-04449913 In Select Hematologic Malignancies
Los Angeles : Childrens Hospital Los Angeles
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Mission Hills : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Rancho Mirage : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
San Diego : Pfizer Investigational Site
A Study Of PF-04449913 In Select Hematologic Malignancies
San Diego : UCSD Moores Cancer Research Institute
Intravenous Administration of RGI-2001 in Patient Undergoing Allogenic Hematopoietic Stem Cell Transplantation (AHSCT)
San Francisco : Investigational Site Number 840005
Dose Escalation Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies
San Francisco : Investigational Site Number 840001 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Stockton : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Colorado
Englewood : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Connecticut
New Haven : Yale Comprehensive Cancer Center at Yale University School of Medicine
A Trial of Extracorporeal Photopheresis, Pentostatin, and Total Body Irradiation in Patients Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation for the Treatment of Malignancies
Torrington : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Delaware
Newark : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Florida
Boynton Beach : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Boynton Beach : Research Site Updated
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Coral Gables : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Hialeah : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Jacksonville : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
View More »
Lakeland : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Miami : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Orlando : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Port St. Lucie : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Sarasota : Florida Cancer Specialists
A Phase 1 Study of IPI-145 in Patients With Advanced Hematologic Malignancies
Stuart : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Tampa : Moffitt Cancer Center
Study of KB004 in Subjects With Hematologic Malignancies
Georgia
Atlanta : Emory University Winship Cancer Institute
A Dose-Escalation and Pharmacokinetic Study of TG02 Citrate in Patients With Advanced Hematological Malignancies
Atlanta : Site Reference ID/Investigator# 26523 Updated
ABT-348 as Monotherapy and in Combination With Azacitidine to Treat Advanced Hematologic Malignancies
Atlanta : Winship Cancer Institute
Study of MLN4924, a Novel Inhibitor of Nedd8 Activating Enzyme, in Adult Patients With Lymphoma or Multiple Myeloma
Dublin : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Hawaii
Honolulu : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Illinois
Chicago : Rush University Medical Center
A Dose-Escalation and Pharmacokinetic Study of TG02 Citrate in Patients With Advanced Hematological Malignancies
Chicago : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Decatur : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Joliet : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Maywood : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
View More »
Maywood : Loyola University, Cardinal Bernardin Cancer Center
Pilot Study Evaluating Safety & Efficacy of DCBT: NiCord® & UNM CBU to Patients With Hematological Malignancies
Maywood : Loyola University Medical Center, Cardinal Bernardin Cancer Center
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy
Maywood : Loyola University Medical Center
Umbilical Cord Transplantation for the Elderly Population
Niles : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Peoria : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Skokie : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Urbana : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Indiana
Anderson : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Avon : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Fort Wayne : Research Site Updated
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Indianapolis : Community Regional Cancer Center-Community Hospital North
Home-Based Symptom Monitoring: Its Impact on Cancer Care Team Behaviors and Patient Outcomes
Indianapolis : Quality Oncology Care, Inc.
Home-Based Symptom Monitoring: Its Impact on Cancer Care Team Behaviors and Patient Outcomes
View More »
Martinsville : Morgan Hospital and Medical Center
Home-Based Symptom Monitoring: Its Impact on Cancer Care Team Behaviors and Patient Outcomes
Iowa
Ames : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Cedar Rapids : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Des Moines : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Waterloo : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Kansas
Wichita : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Kentucky
Paducah : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Paducah : Research Site Updated
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Paducah : Investigational Site Number 840003 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Paducah : Investigational Site Number 840002 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Louisiana
Baton Rouge : Investigational Site Number 840013 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Covington : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Metairie : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
New Orleans : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Maine
Lewiston : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Maryland
Baltimore : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Baltimore : Research Site Updated
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Baltimore : Sidney Kimmel Comprehensive Cancer Center
Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy
Baltimore : The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy
Baltimore : Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Trial of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase (MEK) Inhibitor
View More »
Bethesda : Research Site Updated
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Frederick : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Massachusetts
Boston : Tufts-New England Medical Center
A Trial of Extracorporeal Photopheresis, Pentostatin, and Total Body Irradiation in Patients Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation for the Treatment of Malignancies
Boston : Dana Farber Cancer Institute-Hematopoietic Stem Cell Transplant Program
Single Treatment With FT1050 of an Ex-vivo Modultated Umbilical Cord Blood Unit
Boston : Massachusetts General Hospital
Single Treatment With FT1050 of an Ex-vivo Modultated Umbilical Cord Blood Unit
Boston : Dana Farber Cancer Institute
Trial of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase (MEK) Inhibitor
Michigan
Detroit : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Minnesota
Duluth : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Minneapolis : University of Minnesota: Masonic Cancer Center, BMT Clinic, and Fairview Medical Center
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy
Rochester : Mayo Clinic Updated
A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers
Rochester : Investigational Site Number 840008 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Rochester : Investigational Site Number 840007 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
View More »
Saint Cloud : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Missouri
Saint Louis : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Springfield : Research Site Updated
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Montana
Billings : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Great Falls : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Missoula : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Nebraska
Lincoln : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Omaha : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
New Hampshire
Dover : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
New Jersey
Denville : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Hackensack : Research Site
AMG 319 Lymphoid Malignancy FIH
Newark : Investigational Site Number 840009 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Newark : Investigational Site Number 840006 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Somerville : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
New York
East Syracuse : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Great Neck : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Lake Success : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Manhasset : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
New York City : Weill Cornell Medical College NY Presbyterian Hospital
A Dose-Escalation and Pharmacokinetic Study of TG02 Citrate in Patients With Advanced Hematological Malignancies
View More »
Rochester : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Stony Brook : Research Site
Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Leukemias and Related Disorders
North Carolina
Charlotte : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Durham : Research Site
AMG 319 Lymphoid Malignancy FIH
Durham : Pediatric Bone and Cord Blood, Duke Univ. Med. Center
Evaluation of the Safety and Efficacy of TXA127 (Angiotensin 1-7) to Enhance Engraftment in Pediatric Patients Undergoing Single or Double Umbilical Cord Blood Transplantation
Durham : Duke University Medical Center
Pilot Study Evaluating Safety & Efficacy of DCBT: NiCord® & UNM CBU to Patients With Hematological Malignancies
Durham : Duke University Medical Center Pediatric Blood and Marrow Transplant
Unrelated Cord Blood Transplant Plus a Haplo-Identical (Half-Matched), T-Cell Depleted Stem Transplant From a Related Donor for Subjects With High Risk Malignancies
View More »
Fayetteville : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Gastonia : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
High Point : Research Site Updated
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
North Dakota
Bismarck : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Fargo : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Ohio
Akron : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Canton : Investigational Site Number 840002 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Cincinnati : Investigational Site Number 840004
Dose Escalation Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies
Cleveland : Case Western Reserve University, University Hospitals of Cleveland
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy
Cleveland : Cleveland Clinic, Taussig Cancer Institute
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy
View More »
Columbus : Ohio State University
A Dose-Escalation and Pharmacokinetic Study of TG02 Citrate in Patients With Advanced Hematological Malignancies
Columbus : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Columbus : Ohio State University Comprehensive Cancer Center - The James
Intravenous Administration of RGI-2001 in Patient Undergoing Allogenic Hematopoietic Stem Cell Transplantation (AHSCT)
Columbus : Ohio State Univeristy Comprehensive Cancer Center
Single Treatment With FT1050 of an Ex-vivo Modultated Umbilical Cord Blood Unit
Toedo : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Pennsylvania
Philadelphia : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Sayre : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
West Reading : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Willow Grove : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
South Carolina
Charleston : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
South Dakota
Rapid City : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Sioux Falls : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Watertown : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Tennessee
Germantown : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Memphis : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Nashville : Sarah Cannon Research Institute
A Phase 1 Study of IPI-145 in Patients With Advanced Hematologic Malignancies
Nashville : Sarah Cannon Research Institute Updated
A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers
Nashville : Investigational Site Number 840001
Dose Escalation Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies
Texas
Amarillo : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Amarillo : Texas Oncology
Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match
Autstin : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Corpus Christi : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Dallas : Mary Crowley Cancer Research Centers - Medical City Updated
A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers
View More »
Galveston : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Houston : UT MD Anderson Cancer Center
4'-Thio-araC (Thiarabine) in Advanced Hematologic Malignancies
Houston : MD Anderson Cancer Center
A Dose-Escalation and Pharmacokinetic Study of TG02 Citrate in Patients With Advanced Hematological Malignancies
Houston : Pfizer Investigational Site
A Study Of PF-04449913 In Select Hematologic Malignancies
Houston : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Houston : Site Reference ID/Investigator# 26522 Updated
ABT-348 as Monotherapy and in Combination With Azacitidine to Treat Advanced Hematologic Malignancies
Houston : Research Site
Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Leukemias and Related Disorders
Houston : MD Anderson Cancer Center
Study of CA-18C3 in Subjects With Advanced Hematologic Malignancies
Houston : MD Anderson Cancer Center
Study of KB004 in Subjects With Hematologic Malignancies
Houston : University of Texas - MD Anderson Cancer Center
Study of MLN4924, a Novel Inhibitor of Nedd8 Activating Enzyme, in Adult Patients With Lymphoma or Multiple Myeloma
Houston : University of Texas - MD Anderson Cancer Center
Trial of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase (MEK) Inhibitor
Killeen : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Round Rock : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
San Antonio : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
San Antonio : Methodist Hospital - Texas Transplant Institute
A Trial of Extracorporeal Photopheresis, Pentostatin, and Total Body Irradiation in Patients Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation for the Treatment of Malignancies
Temple : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Utah
Ogden : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Salt Lake City : Huntsman Cancer Center, University of Utah
A Study of Belinostat in Combination With Warfarin in Patients With Solid Tumors or Hematological Malignancies
Salt Lake City : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Salt Lake City : Investigational Site Number 840002
Dose Escalation Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies
Virginia
Charlottesville : University of Virginia Health System Updated
A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers
Washington
Seattle : Pfizer Investigational Site
A Study Of PF-04449913 In Select Hematologic Malignancies
Seattle : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Seattle : Fred Hutchinson Cancer Research Center
Intravenous Administration of RGI-2001 in Patient Undergoing Allogenic Hematopoietic Stem Cell Transplantation (AHSCT)
Seattle : Seattle Cancer Care Alliance
Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological Malignancies
Tacoma : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
View More »
Wenatchee : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
West Virginia
Morgantown : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Wisconsin
Green Bay : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
La Crosse : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Madison : University of Wisconsin
Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological Malignancies
Wauwatosa : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Australia
Adelaide : Royal Adelaide Hospital
Study of KB004 in Subjects With Hematologic Malignancies
Box Hill : Investigational Site Number 036001 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Clayton : Investigational Site Number 036001 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Kingswood : Investigational Site Number 036002 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Kogarah : Investigational Site Number 036004 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
View More »
Melbourne : GSK Investigational Site
Continuation Study of the Oral AKT Inhibitor GSK2110183
Prahran : The Alfred Hospital
Study of KB004 in Subjects With Hematologic Malignancies
Randwick : Investigational Site Number 036003 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Randwick : Investigational Site Number 036003 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
South Granville : Merck Sharp & Dohme (Australia) Pty Ltd.
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Wodonga : Investigational Site Number 036002 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Austria
Vienna : Merck Sharp & Dohme Gmbh
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Belgium
Antwerpen : Investigational Site Number 056003 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Bruxelles : Merck Sharp & Dohme B.V.
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Bruxelles : Investigational Site Number 056002 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Leuven : Investigational Site Number 056001 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Bulgaria
Sofia : Merck Sharp & Dohme IDEA Inc.
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Canada
Halifax : Queen Elizabeth II Health Sciences Centre
Thymoglobulin in Unrelated Hematopoietic Progenitor Cell Transplantation
Hamilton : Juravinski Hospital & Cancer Centre
Thymoglobulin in Unrelated Hematopoietic Progenitor Cell Transplantation
Kirkland : Merck Frosst Canada Ltd.
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Montreal : Investigational Site Number 124002 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Montreal : Hopital Maisonneuve-Rosemont
Thymoglobulin in Unrelated Hematopoietic Progenitor Cell Transplantation
View More »
Montréal : Investigational Site Number 124001 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Saint John : Investigational Site Number 124002 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Toronto : GSK Investigational Site
Continuation Study of the Oral AKT Inhibitor GSK2110183
Toronto : Investigational Site Number 124003 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Vancouver : Vancouver General Hospital
Thymoglobulin in Unrelated Hematopoietic Progenitor Cell Transplantation
Winnipeg : CancerCare Manitoba
Thymoglobulin in Unrelated Hematopoietic Progenitor Cell Transplantation
Chile
Santiago : Merck Sharp & Dohme (I.A.) Corp.
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Colombia
Bogota : Frosst Laboratories Inc.
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Croatia
Zagreb : Merck Sharp & Dohme IDEA, Inc.
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Czech Republic
Praha : Merck Sharp & Dohme IDEA Inc.
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Ecuador
Quito : Merck Sharp and Dohme (I.A.) Corp. Ecuador
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Estonia
Tallinn : Merck Sharp & Dohme IDEA, Inc.
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
France
Lille Cedex : Investigational Site Number 250002 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Lyon : Centre Hospitalier Lyon Sud
Phase I Study of mPEG-R-Crisantaspase Given IV
Lyon Cedex : Hospital Edouard Herriot, Service d'Hematologie Clinique
Trial of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase (MEK) Inhibitor
Marseille : Investigational Site Number 250003 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Nantes : Hospital Hotel Dieu, Service D'Hematologie
Trial of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase (MEK) Inhibitor
View More »
Nantes Cedex 01 : Investigational Site Number 250005 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Nimes : Investigational Site Number 250004 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Paris : Hospital Saint Louis, Service D'Hematologie
Trial of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase (MEK) Inhibitor
Paris Cedex 10 : Investigational Site Number 250001 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Paris Cedex 8 : Laboratoires Merck Sharp & Dohme - Chibret
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Pessac : CHU du Haut-Leveque, Service des Matadies du Sang Unite de Recherche Clinique
Trial of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase (MEK) Inhibitor
Pierre Benite Cedex : Investigational Site Number 250002 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Toulouse : Investigational Site Number 250003 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Villejuif Cedex : Investigational Site Number 250001 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Germany
Aachen : Investigational Site Number 276006 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Bonn : Investigational Site Number 276007 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Frankfurt Am Main : Investigational Site Number 276004 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Haar : Msd Sharp & Dohme Gmbh
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Hannover : Investigational Site Number 276004 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
View More »
Jena : Investigational Site Number 276002 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Jena : Investigational Site Number 276001 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Köln : Universiätsklinikum Köln
Oral Histone Deacetylase Inhibitor 4SC-202 in Patients With Advanced Hematologic Malignancies (TOPAS)
Mannheim : Investigational Site Number 276001 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Mannheim : Investigational Site Number 276003 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Stuttgart : Robert-Bosch-Krankenhaus
Oral Histone Deacetylase Inhibitor 4SC-202 in Patients With Advanced Hematologic Malignancies (TOPAS)
Ulm : Investigational Site Number 276002 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Würzburg : Universitätsklinikum Würzburg
Oral Histone Deacetylase Inhibitor 4SC-202 in Patients With Advanced Hematologic Malignancies (TOPAS)
Greece
Nea Erythrea : Vianex, S.A. / MSD
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Honduras
Honduras Site Information : Merck Sharp & Dohme (IA) Corp.
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Hong Kong
Causeway Bay : Merck Sharp & Dohme (Asia) Ltd.
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Hungary
Budapest : Investigational Site Number 348004 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Debrecen : Investigational Site Number 348001 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Györ : Investigational Site Number 348007 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Kecskemét : Investigational Site Number 348006 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Miskolc : Investigational Site Number 348003 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
View More »
Pécs : Investigational Site Number 348005 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Israel
Haifa : Investigational Site Number 376003 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Jerusalem : Hadassah-Hebrew University Medical Center
A Phase I/II Study of Mis-Matched Immune Cells (AlloStim) in Patients With Advanced Hematological Malignancy
Jerusalem : Investigational Site Number 376004 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Petah-Tikva : Investigational Site Number 376001 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Tel Hashomer : Investigational Site Number 376002 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Italy
Bergamo : Investigational Site Number 380002 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Bologna : Pfizer Investigational Site
A Study Of PF-04449913 In Select Hematologic Malignancies
Bologna : Updated
A Study of RO5045337 [RG7112] in Patients With Hematologic Neoplasms.
Bologna : Investigational Site Number 380007 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Bologna : Investigational Site Number 380003 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
View More »
Firenze : Investigational Site Number 380004 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Firenze : Investigational Site Number 380001 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Milan : Merck Sharp & Dohme (Italia) S.P.A.
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Orbassano : Investigational Site Number 380004 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Pavia : Investigational Site Number 380006 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Pavia : Investigational Site Number 380001 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Roma : Investigational Site Number 380002 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Varese : Investigational Site Number 380003 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Japan
Fukuoka : Research site Updated
A Phase 1, Dose-escalation Study of MEDI-551 in Japanese Adult Patients With Relapsed or Refractory Advanced B-cell Malignancies
Isehara : Research site Updated
A Phase 1, Dose-escalation Study of MEDI-551 in Japanese Adult Patients With Relapsed or Refractory Advanced B-cell Malignancies
Nagoya :
Phase I Study of OPB-51602 in Patients With Hematologic Malignancies
Nagoya-shi : Research site Updated
A Phase 1, Dose-escalation Study of MEDI-551 in Japanese Adult Patients With Relapsed or Refractory Advanced B-cell Malignancies
Tokyo :
Phase I Study of OPB-51602 in Patients With Hematologic Malignancies
Korea, Republic of
Seongnam : Investigational Site Number 410002 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Seongnam : Investigational Site Number 410001 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Seoul : MSD Korea Ltd.
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Seoul : GSK Investigational Site
Continuation Study of the Oral AKT Inhibitor GSK2110183
Seoul : Investigational Site Number 410005 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
View More »
Seoul : Investigational Site Number 410006 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Seoul : Investigational Site Number 410007 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Seoul : Investigational Site Number 410003 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Seoul : Investigational Site Number 410004 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Seoul : Seoul National University Hospital
Study of Epidermal Growth Factor on Oral Mucositis Induced by Intensive Chemotherapy for Hematologic Malignancies
Seoul : Investigational Site Number 410002 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Seoul : Investigational Site Number 410003 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Seoul : Investigational Site Number 410004 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Lithuania
Kaunas : Investigational Site Number 440001 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Klaipeda : Investigational Site Number 440002 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Vilnius : UAB Merck Sharp & Dohme
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Mexico
Mexico City : Merck Sharp & Dohme De Mexico, S.A. De C.V.
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Netherlands
Nijmegen : Investigational Site Number 528001
Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib
New Zealand
Auckland : Merck Sharp & Dohme (New Zealand) Ltd.,
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Peru
Surquillo : Merck Sharp & Dohme, Peru S.R.L.
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Philippines
Makati City : Merck Sharp & Dohme (I.A.) Corporation
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Portugal
Coimbra : Investigational Site Number 620005 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Lisboa : Investigational Site Number 620001 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Lisboa : Investigational Site Number 620004 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Porto : Investigational Site Number 620003 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Puerto Rico
Ponce : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
San Juan : Call for Information
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Romania
Brasov : Investigational Site Number 642003 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Bucuresti : Investigational Site Number 642002 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Timisoara : Investigational Site Number 642001 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Russian Federation
Moscow : Merck Sharp & Dohme IDEA, Inc.
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Moscow : Investigational Site Number 643001 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Petrozavodsk : Investigational Site Number 643008 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
St.-Petersburg : Investigational Site Number 643005 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
St-Petersburg : Investigational Site Number 643004 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
View More »
Volgograd : Investigational Site Number 643007 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Singapore
Singapore : Merck Sharp & Dohme (Singapore)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Singapore : Investigational Site Number 702001 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Singapore : Investigational Site Number 702002 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Slovakia
Bratislava 2 : Merck, Sharp & Dohme
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
South Africa
Johannesburg : Investigational Site Number 710003 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Midrand : MSD (Pty) LTD South Africa
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Parktown : Investigational Site Number 710002 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Spain
Badalona : Investigational Site Number 724004 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Badalona : Investigational Site Number 724004 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Barcelona : Investigational Site Number 724001 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Barcelona : Investigational Site Number 724001 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Madrid : Merck Sharp & Dohme De Espana, S.A.E.
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
View More »
Madrid : Investigational Site Number 724002 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Madrid : Investigational Site Number 724003 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Valencia : Investigational Site Number 724002 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Sweden
Stockholm : Investigational Site Number 752001 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Uddevalla : Investigational Site Number 752002 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Taiwan
Taipei : Merck Sharp & Dohme (I.A.) Corp.
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Thailand
Bangkok : MSD (Thailand) Ltd.
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
United Kingdom
Belfast : Investigational Site Number 826006 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Belfast : Investigational Site Number 826001 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Birmingham : Investigational Site Number 826003 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Birmingham : Investigational Site Number 826006 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Glasgow : Updated
A Study of RO5045337 [RG7112] in Patients With Hematologic Neoplasms.
View More »
Glasgow : Investigational Site Number 826002 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Hoddesdon : Merck Sharp & Dohme Ltd.
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1)
Leeds : Investigational Site Number 826004 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Leeds : Investigational Site Number 826007 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
London : Investigational Site Number 826001
Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib
London : Investigational Site Number 826001 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
London : Investigational Site Number 826005 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
London : King's College Hospital
Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological Malignancies
London : University College London
Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological Malignancies
London : Investigational Site Number 826003 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
London : Investigational Site Number 826004 Updated
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
London : Imperial College NHS Trust
WT1 Immunity Via DNA Fusion Gene Vaccination in Haematological Malignancies by Intramuscular Injection Followed by Intramuscular Electroporation
Manchester : Investigational Site Number 826007 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Manchester : The Christie NHS Foundation
Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological Malignancies
Newcastle Upon Tyne : Investigational Site Number 826008 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Newcastle upon Tyne : University of Newcastle Upon Tyne, NHS Foundation Trust
Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological Malignancies
Oxford : Investigational Site Number 826009 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Southampton : Investigational Site Number 826010 Updated
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Southampton : Southampton University Hospitals NHS Trust
WT1 Immunity Via DNA Fusion Gene Vaccination in Haematological Malignancies by Intramuscular Injection Followed by Intramuscular Electroporation
